Abstract
Monoamine oxidase inhibitors (MAOIs) are the most effective treatment for some forms of depression. Unfortunately, these agents cause many adverse reactions and interact with a number of other drugs. We review the pharmacology, side effects, and interactions of MAOIs, and focus on how MAOI-treated patients can be safely managed in critical care settings.
Get full access to this article
View all access options for this article.
References
1.
Gilman
AG
Goodman
LS
Gilman
A
The pharamacological basis of therapeutics , ed 7 . New York : McMillan ,1985 :165 ;210 ;423 –426
2.
Shader
RI
Current clinical applications of monoamine oxidase inhibitors: Issues, and concerns In:
Shader
RI
, ed. MAOI therapy.
New York : Audio Visual Medical Marketing ,1988 :13 –29
3.
Rabkin
JG
Quitkin
FM
Harrison
W
Update on side-effects associated with MAOIs, and their management In:
Shader
RI
ed. MAOI therapy.
New York : Audio Visual Medical Marketing ,1988 :33 –43
4.
Zisook
S
Side-effects of isocarboxacid
J Clin Psychiatry
1984 ; 45 : 53 –58
5.
Walker
JI
Davidson
J
Zung
WWK
Patient compliance with MAO inhibitor therapy
J Clin Psychiatry
1984 ; 45 : 78 –80
6.
Shawcross
C
Tyrer
P
The place of monoamine oxidase inhibitors in the treatment of resistant depression .
Zohar
J
Belmaker
RH
, eds. In: Treating resistant depression.
Great Neck, NY : PMA Publishing ,1987 :113 –129
7.
Mann
JJ
Aarons
SF
Frances
AJ
Studies of selective and reversible monoamine oxidase inhibitors
J Clin Psychiatry
1984 ; 45 : 62 –66
8.
Murphy
DL
Garrick
NA
Aulakh
CS
New contributions from basic science to understanding the effect of monoamine oxidase inhibiting antidepressants
J Clin Psychiatry
1984 ; 45 : 37 –43
9.
Murphy
DL
Cohen
RM
Sunderland
T
Selective monoamine oxidase inhibitors in treatment-resistant depression .
Zohar
J
Belmaker
RH
eds. In: Treating resistant depression.
Great Neck, NY : PMA Publishing ,1987 :257 –268
10.
Bassuk
EL
Schoonover
SC
Gelenberg
AJ
The practitioner's guide to psychoactive drugs , ed 2 . New York : Plenum ,1983 :57 –63
11.
Linet
LS
Mysterious MAOI hypertensive episodes
J Clin Psychiatry
1986 ; 47 : 563 –565
12.
Davidson
J
Zung
WWK
Walker
JI
Practical aspects of MAO inhibitor therapy
J Clin Psychiatry
1984 ; 45 : 81 –84
13.
Shulman
KI
Walker
SE
MacKenzie
S
Dietary restrictions, tyramine, and the use of monoamine oxidase inhibitors
J Clin Psychopharmacol
1989 ; 9 : 397 –402
14.
Folks
DG
Monoamine oxidase inhibitors: Reappraisal of dietary considerations
J Clin Psychopharmacol
1983 ; 3 : 249 –252
15.
Sullivan
EA
Shulman
KI
Diet and monoamine oxidase inhibitors: A re-examination
Can J Psychiatry
1984 ; 29 : 707 –711
16.
Simpson
GM
White
K
Tyramine studies and the safety of MAOI drugs
J Clin Psychiatry
1984 ; 45 : 59 –61
17.
White
K
Simpson
G
The combined use of MAOIs and tricyclics
J Clin Psychiatry
1984 ; 45 : 67 –69
18.
MAOI/narcotic interactions.
MGH newsletter: Biological Therapies in Psychiatry.
1988 ;11 :21 –24
19.
Simpson
GM
White
K
Silver
P
Management of hypertensive crisis in patients on MAOIs In:
Shader
RI
ed. MAOI therapy.
New York : Audio Visual Medical Marketing ,1988 :45 –52
20.
Browne
B
Linter
S
Monoamine oxidase inhibitors and narcotic analgesics—a critical review of the implications for treatment
Br J Psychiatry
1987 ; 151 : 210 –212
21.
Fallon
B
Foote
B
Walsh
BT
“Spontaneous” hypertensive episodes with monoamine oxidase inhibitors
J Clin Psychiatry
1988 ; 49 : 163 –165
22.
MAOIs: Assorted concerns. MGH newsletter:
Biological Therapies in Psychiatry.
1988 ;11 :34 –36
23.
Linden
CH
Rumack
BH
Strehlke
C
Monoamine oxidase inhibitor overdose
Ann Emerg Med
1984 ; 13 : 1137 –1144
24.
Clary
C
Schweizer
E
Treatment of MAOI hypertensive crisis with sublingual nifedipine
J Clin Psychiatry
1987 ; 48 : 249 –250
25.
White
K
Simpson
GM
Management of MAOI overdoses, and hyperthermic crisis In:
Shader
RI
ed. MAOI Therapy.
New York : Audio Visual Medical Marketing ,1988 :53 –61
26.
Verelli
MR
Salanga
VD
Kozachuk
WE
Phenelzine toxicity responsive to dantrolene
Neurology
1987 ; 37 : 865 –867
27.
Kaplan
RF
Feinglass
NG
Webster
W
Phenelzine overdose treated with dantrolene sodium
JAMA
1986 ; 255 : 642 –644
28.
Ciraulo
DA
Creelman
W
Drug-drug interactions with monoamine oxidase inhibitors In:
Shader
RI
ed. MAOI Therapy.
New York : Audio Visual Medical Marketing ,1988 :63 –72
29.
Michaels
I
Serrins
M
Shier
NQ
Anesthesia for cardiac surgery in patients receiving monoamine oxidase inhibitors
Anesth Analg
1984 ; 63 : 1041 –1044
30.
Cameron
AG
Monoamine oxidase inhibitors and general anaesthesia
Anaesth Intensive Care
1986 ; 14 : 210
31.
Sides
CA
Hypertension during anaesthesia with monoamine oxidase inhibitors
Anaesthesia
1987 ; 42 : 633 –635
32.
Freese
KJ
Can patients safely undergo electroconvulsive therapy while receiving monoamine oxidase inhibitors?
Convulsive Therapy
1985 ; 1 :190 –194
33.
El-Ganzouri
AR
Ivankovich
AD
Braverman
B
Monoamine oxidase inhibitors: Should they be discontinued pre-operatively?
Anesth Analg
1985 ; 64 :592 –596
34.
Stack
CG
Rogers
P
Linter
SPK
Monoamine oxidase inhibitors and anaesthesia
Br J Anaesth
1988 ; 60 : 222 –227
35.
Baldessarini
R
Chemotherapy in psychiatry: principles and practice.
Cambridge, MA : Harvard University Press ,1985 ; 201 –215